Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

How our clients use DrugPatentWatch

Generated: May 25, 2017

DrugPatentWatch Database Preview

Cladribine - Generic Drug Details

« Back to Dashboard

What are the generic drug sources for cladribine and what is the scope of cladribine freedom to operate?

Cladribine
is the generic ingredient in two branded drugs marketed by West-ward Pharms Int, Mylan Labs Ltd, Janssen Pharms, and Fresenius Kabi Usa, and is included in four NDAs. There is one patent protecting this compound. Additional information is available in the individual branded drug profile pages.

There are seven drug master file entries for cladribine. Three suppliers are listed for this compound.

Summary for Generic Name: cladribine

Tradenames:2
Patents:1
Applicants:4
NDAs:4
Drug Master File Entries: see list7
Suppliers / Packagers: see list3
Bulk Api Vendors: see list70
Clinical Trials: see list35
Patent Applications: see list7,137
Formulation / Manufacturing:see details
Drug Prices:see low prices
DailyMed Link:cladribine at DailyMed

Pharmacology for Ingredient: cladribine

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Janssen Pharms
LEUSTATIN
cladribine
INJECTABLE;INJECTION020229-001Feb 26, 1993DISCNYesNo► Subscribe► Subscribe
West-ward Pharms Int
CLADRIBINE
cladribine
INJECTABLE;INJECTION075405-001Feb 28, 2000APRXNoNo► Subscribe► Subscribe
Fresenius Kabi Usa
CLADRIBINE
cladribine
INJECTABLE;INJECTION076571-001Apr 22, 2004APRXNoYes► Subscribe► Subscribe
Mylan Labs Ltd
CLADRIBINE
cladribine
INJECTABLE;INJECTION200510-001Oct 6, 2011APRXNoNo► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Subscribe for Complete Access

  • Formulary management
  • Uncover prior art in abandoned patent applications and expired patents
  • Set up watchlists for daily email updates

► Plans and Pricing

Expired Orange Book Patents

 Available with subscription

Paragraph IV Activity

 Available with subscription

Patent Maintenance

 Available with subscription

Non-Orange Book Patents

 Available with subscription

International Patents

 Available with subscription

Supplementary Protection Certificates

 Available with subscription

« Back to the Dashboard

For more information try a trial or see the database preview and plans and pricing

How our clients use DrugPatentWatch

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot